Wednesday, Mar 26, 2025 · SEC filings

What the smart money revealed on Mar 26

Real insider buys17insiders · $1.54M
Real insider sales37insiders · $49.5M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

491 insider filings came in. We hid 77 planned (10b5-1) sellers and 339 people whose filings were routine, like grants and tax withholding.

trending_up

Immunome (IMNM) President and CEO Clay Siegall bought $999K

137,100 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 6 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 2 of 6 beat Traded Mar 26
$999K
trending_up

F&G Annuities & Life (FG) Director Celina Doka bought $106K

3,000 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 3 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 0 of 3 beat Traded Mar 25
$106K
trending_up

Prospect Capital (PSEC) CEO John Barry bought $102K

24,000 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 6 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 0 of 6 beat Traded Mar 24
$102K
trending_up

Contango ORE (CTGO) President and CEO Rick Van Nieuwenhuyse bought $99.8K

10,000 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 3 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 3 of 3 beat Traded Mar 25
$99.8K
trending_down

Gitlab (GTLB) Director Matthew Jacobson sold $8M

Not marked as a planned 10b5-1 sale. Sold 6% of the shares they held directly. Still holds 2.62M shares.

Real sale Form 4 Traded Mar 24
$8M
trending_down

Main Street Capital (MAIN) CEO Dwayne Hyzak sold $6.97M

Not marked as a planned 10b5-1 sale. Sold 23% of the shares they held directly. Still holds 402,371 shares.

Real sale Form 4 Traded Mar 26
$6.97M
trending_down

Photronics (PLAB) Director Walter Fiederowicz sold $216K

Not marked as a planned 10b5-1 sale. Sold 25% of the shares they held directly. Still holds 29,548 shares.

Real sale Form 4 Sold 25% of stake Traded Mar 25
$216K
Show 13 more real buys
Show 34 more real sales
AVGO Broadcom · Chief Legal and Corp Affairs Ofc Mark Brazeal · Traded Mar 24
$5.84M
MAIN Main Street Capital · President David Magdol · Traded Mar 26
$5.8M
MSTR Microstrategy · Director Leslie Rechan · Traded Mar 25
$5.04M
DRI Darden Restaurants · President and CEO Ricardo Cardenas · Traded Mar 24
$4.27M
AVAV AeroVironment · Chair Wahid Nawabi · Traded Mar 24
$3.76M
WLFC Willis Lease Finance · EVP Scott Flaherty · Traded Mar 24–26
$2.7M
ADI Analog Devices · EVP Vivek Jain · Traded Mar 24
$2.66M
BBY Best Buy · Sevp Kathleen Scarlett · Traded Mar 21
$497K
DXPE DXP Enterprises · Director Timothy Halter · Traded Mar 24
$449K
BBY Best Buy · GC Todd Hartman · Traded Mar 21
$355K
BBY Best Buy · SEVP Cust Offer Jason Bonfig · Traded Mar 21
$354K
MTZ MasTec · Director Ernst Csiszar · Traded Mar 24
$331K
IRON Disc Medicine · Director Mona Ashiya · Traded Mar 24
$310K
TARS Tarsus Pharmaceuticals · President/CEO and Board Chair Bobak Azamian · Traded Mar 24
$300K
BBY Best Buy · Sevp Damien Harmon · Traded Mar 21
$294K
BBY Best Buy · SVP Mathew Watson · Traded Mar 21
$214K
BOX Box · VP Chief Acct Ofr and Controller Eli Berkovitch · Traded Mar 24
$173K
KRC Kilroy Realty · EVP John Osmond · Traded Mar 25
$141K
ATLC Atlanticus · Director Deal Hudson · Traded Mar 24
$126K
PGR Progressive · Director Devin Johnson · Traded Mar 25
$110K
M Macy's · EVP Danielle Kirgan · Traded Mar 25–26
$110K
M Macy's · EVP Adrian Mitchell · Traded Mar 25–26
$107K
M Macy's · Chairman and CEO Antony Spring · Traded Mar 25–26
$103K
SEGG Lottery.com · Director Christopher Gooding · Traded Feb 25
$55.6K
ACAD Acadia Pharmaceuticals · EVP Mark Schneyer · Traded Mar 26
$54.1K
CLMT Calumet · Director Stephen Mawer · Traded Mar 24
$47.1K
AMBA Ambarella · Director Christopher Paisley · Traded Mar 25
$27.8K
GTE Gran Tierra Energy · Director David Smith · Traded Mar 26
$24.7K
CYRX Cryoport · President Jerrell Shelton · Traded Mar 24
$20.7K
M Macy's · SVP and Controller Paul Griscom · Traded Mar 25–26
$19.8K
ACAD Acadia Pharmaceuticals · Principal Accounting Officer James Kihara · Traded Mar 26
$18.7K
TRVI Trevi Therapeutics · Chief Scientific Officer Thomas Sciascia · Traded Mar 25
$17.4K
CYRX Cryoport · Chief Scientific Officer Mark Sawicki · Traded Mar 24
$9.36K
CYRX Cryoport · CFO Robert Stefanovich · Traded Mar 24
$7.43K

13F season

Holdings as of Dec 31, 2024 were due Feb 14

81 funds have filed. 58 filed for the quarter before.

Biggest real insider buys, Mar 20–26

Open-market buys by officers and directors, filed in the 7 days up to Mar 26.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist